Download
s13058-021-01413-y.pdf 1,81MB
WeightNameValue
1000 Titel
  • Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials
1000 Autor/in
  1. Graeser, Monika |
  2. Schrading, Simone |
  3. Gluz, Oleg |
  4. Strobel, Kevin |
  5. Herzog, Christopher |
  6. Umutlu, Lale |
  7. Frydrychowicz, Alex |
  8. Rjosk-Dendorfer, Dorothea |
  9. Würstlein, Rachel |
  10. Culemann, Ralph |
  11. Eulenburg, Christine |
  12. Adams, Jascha |
  13. Nitzsche, Henrik |
  14. Prange, Anna |
  15. Kümmel, Sherko |
  16. Grischke, Eva-Maria |
  17. Forstbauer, Helmut |
  18. Braun, Michael |
  19. Potenberg, Jochem |
  20. von Schumann, Raquel |
  21. Aktas, Bahriye |
  22. Kolberg-Liedtke, Cornelia |
  23. Harbeck, Nadia |
  24. Kuhl, Christiane K. |
  25. Nitz, Ulrike |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-03-18
1000 Erschienen in
1000 Quellenangabe
  • 23(1):36
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13058-021-01413-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977310/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Prediction of histological tumor size by post-neoadjuvant therapy (NAT) ultrasound and magnetic resonance imaging (MRI) was evaluated in different breast cancer subtypes.!##!Methods!#!Imaging was performed after 12-week NAT in patients enrolled into three neoadjuvant WSG ADAPT subtrials. Imaging performance was analyzed for prediction of residual tumor measuring ≤10 mm and summarized using positive (PPV) and negative (NPV) predictive values.!##!Results!#!A total of 248 and 588 patients had MRI and ultrasound, respectively. Tumor size was over- or underestimated by < 10 mm in 4.4% and 21.8% of patients by MRI and in 10.2% and 15.8% by ultrasound. Overall, NPV (proportion of correctly predicted tumor size ≤10 mm) of MRI and ultrasound was 0.92 and 0.83; PPV (correctly predicted tumor size > 10 mm) was 0.52 and 0.61. MRI demonstrated a higher NPV and lower PPV than ultrasound in hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-positive and in HR-/HER2+ tumors. Both methods had a comparable NPV and PPV in HR-/HER2- tumors.!##!Conclusions!#!In HR+/HER2+ and HR-/HER2+ breast cancer, MRI is less likely than ultrasound to underestimate while ultrasound is associated with a lower risk to overestimate tumor size. These findings may help to select the most optimal imaging approach for planning surgery after NAT.!##!Trial registration!#!Clinicaltrials.gov , NCT01815242 (registered on March 21, 2013), NCT01817452 (registered on March 25, 2013), and NCT01779206 (registered on January 30, 2013).
1000 Sacherschließung
lokal Breast Neoplasms/diagnostic imaging [MeSH]
lokal Female [MeSH]
lokal Aged [MeSH]
lokal Receptors, Estrogen/metabolism [MeSH]
lokal Adult [MeSH]
lokal Receptor, ErbB-2/metabolism [MeSH]
lokal Receptors, Progesterone/metabolism [MeSH]
lokal Humans [MeSH]
lokal Breast cancer
lokal Breast Neoplasms/drug therapy [MeSH]
lokal Residual tumor size
lokal Predictive Value of Tests [MeSH]
lokal Breast Neoplasms/metabolism [MeSH]
lokal Middle Aged [MeSH]
lokal Neoadjuvant Therapy [MeSH]
lokal Ultrasound
lokal Magnetic Resonance Imaging [MeSH]
lokal Neoadjuvant therapy
lokal Magnetic resonance imaging
lokal Neoplasm, Residual [MeSH]
lokal Tumor Burden [MeSH]
lokal Research Article
lokal Breast Neoplasms/pathology [MeSH]
lokal Ultrasonography, Mammary [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-1916-717X|https://frl.publisso.de/adhoc/uri/U2NocmFkaW5nLCBTaW1vbmU=|https://frl.publisso.de/adhoc/uri/R2x1eiwgT2xlZw==|https://frl.publisso.de/adhoc/uri/U3Ryb2JlbCwgS2V2aW4=|https://frl.publisso.de/adhoc/uri/SGVyem9nLCBDaHJpc3RvcGhlcg==|https://frl.publisso.de/adhoc/uri/VW11dGx1LCBMYWxl|https://frl.publisso.de/adhoc/uri/RnJ5ZHJ5Y2hvd2ljeiwgQWxleA==|https://frl.publisso.de/adhoc/uri/Umpvc2stRGVuZG9yZmVyLCBEb3JvdGhlYQ==|https://frl.publisso.de/adhoc/uri/V8O8cnN0bGVpbiwgUmFjaGVs|https://frl.publisso.de/adhoc/uri/Q3VsZW1hbm4sIFJhbHBo|https://frl.publisso.de/adhoc/uri/RXVsZW5idXJnLCBDaHJpc3RpbmU=|https://frl.publisso.de/adhoc/uri/QWRhbXMsIEphc2NoYQ==|https://frl.publisso.de/adhoc/uri/Tml0enNjaGUsIEhlbnJpaw==|https://frl.publisso.de/adhoc/uri/UHJhbmdlLCBBbm5h|https://frl.publisso.de/adhoc/uri/S8O8bW1lbCwgU2hlcmtv|https://frl.publisso.de/adhoc/uri/R3Jpc2Noa2UsIEV2YS1NYXJpYQ==|https://frl.publisso.de/adhoc/uri/Rm9yc3RiYXVlciwgSGVsbXV0|https://frl.publisso.de/adhoc/uri/QnJhdW4sIE1pY2hhZWw=|https://frl.publisso.de/adhoc/uri/UG90ZW5iZXJnLCBKb2NoZW0=|https://frl.publisso.de/adhoc/uri/dm9uIFNjaHVtYW5uLCBSYXF1ZWw=|https://frl.publisso.de/adhoc/uri/QWt0YXMsIEJhaHJpeWU=|https://frl.publisso.de/adhoc/uri/S29sYmVyZy1MaWVkdGtlLCBDb3JuZWxpYQ==|https://frl.publisso.de/adhoc/uri/SGFyYmVjaywgTmFkaWE=|https://frl.publisso.de/adhoc/uri/S3VobCwgQ2hyaXN0aWFuZSBLLg==|https://frl.publisso.de/adhoc/uri/Tml0eiwgVWxyaWtl
1000 Hinweis
  • DeepGreen-ID: 5a4def6b377c4395b647e9b8b956dfd9 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463939.rdf
1000 Erstellt am 2023-11-15T22:55:52.960+0100
1000 Erstellt von 322
1000 beschreibt frl:6463939
1000 Zuletzt bearbeitet Thu Nov 30 22:39:47 CET 2023
1000 Objekt bearb. Thu Nov 30 22:39:47 CET 2023
1000 Vgl. frl:6463939
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463939 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source